• Redefining Firefly Luciferase mRNA: Mechanisms, Delivery, an

  2026-07-22

  This thought-leadership article for translational researchers explores the mechanistic design, experimental performance, and strategic translational guidance surrounding next-generation Firefly Luciferase mRNA tools. By bridging insights from delivery vector innovation and immune modulation to workflow optimization and future clinical translation, we highlight how EZ Cap™ Firefly Luciferase mRNA (5-moUTP) from APExBIO is transforming the landscape for gene regulation studies and beyond.

• Structure-Guided Proteomimetics Disrupt SARS-CoV-2 S-RBD/hAC

  2026-07-22

  This study details the rational design of constrained proteomimetics that selectively target and disrupt the SARS-CoV-2 Spike RBD and hACE2 interaction, a challenging protein–protein interface. The research demonstrates not only the feasibility of mimicking key hACE2 elements but also establishes foundational principles for future antiviral PPI inhibitor development.

• Nicotine’s Role in CKD Progression: Mechanisms and Research

  2026-07-21

  This article reviews the mechanistic insights and clinical evidence linking nicotine exposure to the progression of chronic kidney disease (CKD) in smokers, as detailed by Jain and Jaimes (2013). The review highlights nicotine’s non-neuronal receptor signaling, the resulting oxidative and fibrotic pathways, and emerging strategies for experimental modeling.

• Trichostatin A (TSA): Epigenetic Modulation Beyond Chromatin

  2026-07-21

  Explore how Trichostatin A (TSA) redefines epigenetic regulation in cancer research through its robust inhibition of histone deacetylases and unique impact on centrosome dynamics. This article delves into advanced mechanisms, protocol nuances, and practical insights for leveraging TSA in oncology and cell biology.

• PBS (Phosphate-Buffered Saline): Technical Parameters & Lab

  2026-07-20

  PBS (Phosphate-Buffered Saline) provides a sterile, isotonic buffer solution designed to maintain physiological pH and osmolarity for routine research workflows. It is ideal for procedures such as cell washing, reagent dilution, and sample preparation, but should not be used for diagnostic or clinical applications. Proper storage and handling are critical to ensure experimental reliability.

• MK-8745: Transforming Aurora A Inhibitor Research in Cancer

  2026-07-20

  Explore how MK-8745, a potent Aurora A inhibitor, enables unprecedented precision in cancer research. This article uniquely examines its mechanistic depth and translational opportunities beyond standard protocols.

• EdU Imaging Kits (488): Precision Cell Proliferation Workflo

  2026-07-19

  EdU Imaging Kits (488) streamline S-phase DNA synthesis measurement with click chemistry, offering faster, morphology-preserving workflows versus BrdU. This guide explores real-world protocol enhancements, troubleshooting, and advanced applications in oncology and regenerative medicine.

• Branched Endosomal Disruptor Lipids Enhance mRNA and RNP Del

  2026-07-18

  The referenced study introduces a new class of branched ionizable lipids (BEND) that significantly improve cytosolic delivery of mRNA and CRISPR-Cas9 RNPs by enhancing endosomal escape, with demonstrated applications in hepatic gene editing and T cell engineering. This work advances the design principles for lipid nanoparticle vectors, potentially overcoming key barriers in efficient, safe nucleic acid therapeutics.

• ML216: Unlocking BLM Helicase Inhibition for MSI Cancer Rese

  2026-07-17

  Explore the advanced science behind ML216, a BLM helicase inhibitor, as a precision tool for investigating DNA repair and synthetic lethality in mismatch repair-deficient cancers. This article offers an in-depth analysis of ML216’s mechanism, unique applications, and practical assay insights grounded in recent landmark research.

• Septin4 Promotes Cardiomyocyte Injury via HIF-1α Degradation

  2026-07-17

  This study reveals that Septin4 intensifies hypoxia-induced cardiomyocyte apoptosis by promoting HIF-1α ubiquitination and degradation through the VHL pathway. These findings illuminate a previously unrecognized mechanism underlying myocardial ischemia injury and suggest new targets for modulating hypoxia responses in cardiovascular disease.

• GI 254023X: Precision ADAM10 Inhibitor for Vascular & Cell M

  2026-07-16

  GI 254023X unlocks new experimental workflows for dissecting ADAM10-mediated signaling and vascular barrier integrity. Its unmatched selectivity and robust in vitro/vivo validation set a new benchmark for apoptosis and endothelial injury studies.

• Pioglitazone as a PPARγ Agonist: Advanced Insights for Immun

  2026-07-16

  Explore the multifaceted role of pioglitazone as a PPARγ agonist in immunometabolic research. This article offers an in-depth analysis of mechanism, protocol optimization, and translational impact, bridging metabolic and inflammatory models for next-generation assay design.

• 2',7'-Dichlorofluorescein Diacetate: Optimizing Intracellula

  2026-07-15

  2',7'-Dichlorofluorescein diacetate empowers precise, quantitative intracellular ROS measurement in live-cell assays, transforming cancer biology and redox drug discovery workflows. This guide details advanced protocol enhancements, troubleshooting strategies, and key innovations that set APExBIO’s probe apart for translational research.

• Mono-ADP-Ribosylation Marks PARP7 and AHR for Degradation

  2026-07-15

  This study reveals that endogenous mono-ADP-ribosylation of PARP7 and AHR serves as a degradation signal, uncovered by blocking the ubiquitin pathway. The findings clarify the interplay between ADP-ribosylation and proteasomal degradation, providing new mechanistic insight into AHR signaling regulation.

• Deep Learning Uncovers Cardiotoxicity in iPSC-CMs Screening

  2026-07-14

  Grafton et al. present a scalable deep learning approach for early detection of drug-induced cardiotoxicity using high-content imaging of iPSC-derived cardiomyocytes. This framework enables efficient identification of cardiotoxic compounds and informs safer drug development pipelines.

16050 records 1/1070 page Next 12345 下5页 Last page